News

Filter

Current filters:

Nephrology and Hepatology

1 to 9 of 145 results

Batch of mixed NICE decisions for Xarelto, Imnovid, Jardiance and Targaxan

25-03-2015

The National Institute of Health and Care Excellence (NICE), the medicines cost watchdog for England…

BayerBoehringer IngelheimCardio-vascularCelgene CorpDiabetesImnovidJardianceNephrology and HepatologyNorgineOncologyPharmaceuticalTargaxanUKXarelto

Lack of data and data management hindering hepatitis C progress in England, says IMS Health

Lack of data and data management hindering hepatitis C progress in England, says IMS Health

24-03-2015

Limited data and the disparate nature of the datasets that are available have been challenges to measuring…

Markets & MarketingNephrology and HepatologyPharmaceuticalSocial IssuesUK

Islet Sciences gains certain rights for Phase II SGLT2 inhibitor remogliflozin

Islet Sciences gains certain rights for Phase II SGLT2 inhibitor remogliflozin

03-03-2015

US biotech firm Islet Sciences has entered into a license agreement with Brighthaven Ventures (BHV) for…

BiotechnologyBrighthaven VenturesDiabetesIslet SciencesLicensingNephrology and Hepatologyremogliflozin

Three new drugs recommended for approval by EMA/CHMP

Three new drugs recommended for approval by EMA/CHMP

27-02-2015

Three new medicines have been recommended for approval at the February 2015 meeting of the European Medicines…

AmgenEuropeJinarcNephrology and HepatologyNovartisOncologyOtsuka PharmaceuticalPharmaceuticalRegulationRistempaVectibixZykadia

Advagraf plus basiliximab results in significantly better renal function

23-02-2015

Data published last week in the American Journal of Transplantation demonstrate that in liver transplant…

AdvagrafAstellas PharmaBasiliximabNephrology and HepatologyPharmaceuticalResearch

Astellas' once-daily Advagraf demonstrates superiority to twice-daily immediate release

Astellas' once-daily Advagraf demonstrates superiority to twice-daily immediate release

20-02-2015

Japanese drug major Astellas has published results of a study demonstrating that early and sustained…

AdvagrafAstellasNephrology and HepatologyPharmaceuticalResearch

NICE final draft guidance recommends Norgine's Targaxan

NICE final draft guidance recommends Norgine's Targaxan

19-02-2015

The UK’s National Institute for Health and Care Excellence has published its final draft guidance recommending…

Nephrology and HepatologyNeurologicalNorginePharmaceuticalRegulationTargaxanUK

1 to 9 of 145 results

Back to top